In mammals, DIFs affect the activity of protein kinases such as ERK and GSK-3β in some tumor cells [9]–[12] and arrest the cell cycle at the G0/1 phase by inhibiting the expression of cyclin D and the phosphorylation of retinoblastoma protein [12], [15]. This evidence concerns the gene GSK3B and neoplasm.